1. Home
  2. FFBC vs ARQT Comparison

FFBC vs ARQT Comparison

Compare FFBC & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Financial Bancorp.

FFBC

First Financial Bancorp.

N/A

Current Price

$29.77

Market Cap

2.7B

Sector

Finance

ML Signal

N/A

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

N/A

Current Price

$21.22

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FFBC
ARQT
Founded
1863
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.6B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
FFBC
ARQT
Price
$29.77
$21.22
Analyst Decision
Buy
Strong Buy
Analyst Count
8
6
Target Price
$30.71
$34.00
AVG Volume (30 Days)
735.3K
2.1M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
3.34%
N/A
EPS Growth
10.83
88.79
EPS
0.71
N/A
Revenue
N/A
$376,072,000.00
Revenue This Year
$27.67
$34.85
Revenue Next Year
$4.58
$29.39
P/E Ratio
$41.93
N/A
Revenue Growth
N/A
91.34
52 Week Low
$22.94
$12.72
52 Week High
$31.38
$31.77

Technical Indicators

Market Signals
Indicator
FFBC
ARQT
Relative Strength Index (RSI) 51.51 49.57
Support Level $29.10 $21.12
Resistance Level $31.24 $21.95
Average True Range (ATR) 0.56 0.80
MACD -0.09 0.16
Stochastic Oscillator 44.54 82.82

Price Performance

Historical Comparison
FFBC
ARQT

About FFBC First Financial Bancorp.

First Financial Bancorp is a mid-sized, regional bank holding company. It engages in the business of commercial banking and other banking and banking-related activities through its subsidiary. The range of banking services provided to individuals and businesses includes commercial lending, real estate lending and consumer financing. Real estate loans are loans secured by a mortgage lien on the real property of the borrower, which may either be residential property or commercial property. In addition, it offers deposit products that include interest-bearing and noninterest-bearing accounts, time deposits and cash management services for commercial customers. A full range of trust and wealth management services is also provided through First Financial's Wealth Management line of business.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: